Crinetics Pharmaceuticals (CRNX) Change in Receivables (2026)

Crinetics Pharmaceuticals' (CRNX) quarterly Change in Receivables came in at $5.1 million in Q1 2026.

Crinetics Pharmaceuticals (CRNX) Change in Receivables (2026) Analysis & Trends

Crinetics Pharmaceuticals' Change in Receivables history runs 1 years deep, the most recent figure standing at $5.1 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Oculis Holding AG 67,342.66 Bn 67,342.38 Bn - -
2 Nanobiotix 1,887.92 Bn 1,887.86 Bn - -
3 BeOne Medicines 471.75 Bn 466.96 Bn 1.35 Bn 75.30 Mn
4 Vertex Pharmaceuticals 122.57 Bn 115.32 Bn 2.59 Bn -39.80 Mn
5 Regeneron Pharmaceuticals 69.18 Bn 60.43 Bn 3.31 Bn -1.20 Mn
6 Belite Bio 61.55 Bn 61.55 Bn - -
7 Argenx Se 56.68 Bn 51.50 Bn 1.41 Bn -
8 Revolution Medicines 37.83 Bn 37.83 Bn - -
9 Alnylam Pharmaceuticals 36.81 Bn 33.80 Bn 959.66 Mn 110.42 Mn
10 Crinetics Pharmaceuticals 8.72 Bn 7.43 Bn 10.53 Mn 5.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.09 Mn
Mar 31, 2026 5.09 Mn